Vanguard Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$450M Sell
5,632,986
-2,312
-0% -$185K 0.01% 1090
2025
Q1
$484M Sell
5,635,298
-54,861
-1% -$4.72M 0.01% 1014
2024
Q4
$444M Buy
5,690,159
+8,128
+0.1% +$635K 0.01% 1103
2024
Q3
$410M Sell
5,682,031
-16,592
-0.3% -$1.2M 0.01% 1154
2024
Q2
$392M Sell
5,698,623
-43,387
-0.8% -$2.99M 0.01% 1106
2024
Q1
$417M Sell
5,742,010
-14,128
-0.2% -$1.03M 0.01% 1100
2023
Q4
$352M Buy
5,756,138
+63,375
+1% +$3.88M 0.01% 1184
2023
Q3
$326M Sell
5,692,763
-37,508
-0.7% -$2.15M 0.01% 1160
2023
Q2
$341M Sell
5,730,271
-78,285
-1% -$4.65M 0.01% 1154
2023
Q1
$364M Buy
5,808,556
+59,765
+1% +$3.74M 0.01% 1091
2022
Q4
$360M Buy
5,748,791
+101,169
+2% +$6.33M 0.01% 1062
2022
Q3
$281M Buy
5,647,622
+32,646
+0.6% +$1.63M 0.01% 1178
2022
Q2
$330M Buy
5,614,976
+55,423
+1% +$3.26M 0.01% 1115
2022
Q1
$294M Buy
5,559,553
+59,740
+1% +$3.16M 0.01% 1309
2021
Q4
$334M Buy
5,499,813
+17,258
+0.3% +$1.05M 0.01% 1262
2021
Q3
$308M Sell
5,482,555
-16,483
-0.3% -$925K 0.01% 1309
2021
Q2
$287M Buy
5,499,038
+65,690
+1% +$3.42M 0.01% 1397
2021
Q1
$240M Buy
5,433,348
+595,197
+12% +$26.2M 0.01% 1481
2020
Q4
$169M Buy
4,838,151
+58,810
+1% +$2.05M ﹤0.01% 1558
2020
Q3
$174M Sell
4,779,341
-204,865
-4% -$7.46M 0.01% 1363
2020
Q2
$187M Sell
4,984,206
-104,613
-2% -$3.93M 0.01% 1312
2020
Q1
$187M Buy
5,088,819
+183,618
+4% +$6.74M 0.01% 1172
2019
Q4
$199M Buy
4,905,201
+89,522
+2% +$3.63M 0.01% 1391
2019
Q3
$167M Sell
4,815,679
-82,597
-2% -$2.87M 0.01% 1442
2019
Q2
$155M Buy
4,898,276
+32,075
+0.7% +$1.02M 0.01% 1512
2019
Q1
$146M Buy
4,866,201
+56,765
+1% +$1.7M 0.01% 1536
2018
Q4
$149M Buy
4,809,436
+105,961
+2% +$3.27M 0.01% 1437
2018
Q3
$178M Sell
4,703,475
-202,407
-4% -$7.67M 0.01% 1473
2018
Q2
$188M Sell
4,905,882
-52,627
-1% -$2.02M 0.01% 1393
2018
Q1
$167M Sell
4,958,509
-469,947
-9% -$15.8M 0.01% 1413
2017
Q4
$241M Sell
5,428,456
-503,670
-8% -$22.4M 0.01% 1180
2017
Q3
$297M Buy
5,932,126
+140,697
+2% +$7.05M 0.01% 1004
2017
Q2
$306M Buy
5,791,429
+110,954
+2% +$5.86M 0.02% 966
2017
Q1
$316M Buy
5,680,475
+607,598
+12% +$33.8M 0.02% 924
2016
Q4
$264M Buy
5,072,877
+225,482
+5% +$11.7M 0.01% 987
2016
Q3
$234M Buy
4,847,395
+147,911
+3% +$7.14M 0.01% 1015
2016
Q2
$260M Buy
4,699,484
+39,292
+0.8% +$2.18M 0.02% 894
2016
Q1
$249M Buy
4,660,192
+374,002
+9% +$20M 0.02% 899
2015
Q4
$221M Buy
4,286,190
+305,220
+8% +$15.7M 0.01% 948
2015
Q3
$180M Buy
3,980,970
+119,948
+3% +$5.42M 0.01% 1056
2015
Q2
$179M Buy
3,861,022
+113,660
+3% +$5.26M 0.01% 1130
2015
Q1
$161M Buy
3,747,362
+189,433
+5% +$8.12M 0.01% 1161
2014
Q4
$124M Buy
3,557,929
+75,035
+2% +$2.61M 0.01% 1266
2014
Q3
$113M Buy
3,482,894
+75,122
+2% +$2.43M 0.01% 1264
2014
Q2
$115M Buy
3,407,772
+42,844
+1% +$1.45M 0.01% 1302
2014
Q1
$91.7M Buy
3,364,928
+81,205
+2% +$2.21M 0.01% 1403
2013
Q4
$118M Buy
3,283,723
+206,165
+7% +$7.38M 0.01% 1210
2013
Q3
$92.7M Buy
3,077,558
+70,457
+2% +$2.12M 0.01% 1286
2013
Q2
$87.6M Buy
+3,007,101
New +$87.6M 0.01% 1253